Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
CLSDClearside Biomedical(CLSD) Zacks Investment Research·2024-05-10 07:56

Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of 0.17pershareversustheZacksConsensusEstimateofalossof0.17 per share versus the Zacks Consensus Estimate of a loss of 0.14. This compares to loss of 0.15pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−21.430.15 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -21.43%. A quarter ago, it was expected that this company would post a loss of 0.10 per share when it actually produced a loss of $0.08, delivering a surprise of 20%. Over the last four quarters, the company h ...